IRIS

CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 109 (tempo di esecuzione: 0.041 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Molecular heterogeneity of RET loss of function in Hirschsprung's disease 1.1 Articolo in rivista 1996 Carlomagno, Francesca; DE VITA, Gabriella; Berlingieri, Mt; DE FRANCISCIS, V; Melillo, ROSA MARINA; Colantuoni, V; Kraus, Mh; DI FIORE, Pp; Fusco, Alfredo; Santoro, M.
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. 1.1 Articolo in rivista 2007 Allocca, M; DI VICINO, U; Petrillo, M; Carlomagno, Francesca; Domenici, L; Auricchio, Alberto
Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A 1.1 Articolo in rivista 1994 Quadro, L; Panariello, L; Salvatore, D; Carlomagno, Francesca; DEL PRETE, M; Nunziata, V; Colantuoni, V; DI GIOVANNI, G; Brandi, Ml; Mannelli, M; Gheri, R; Verga, U; Libroia, A; Berger, N; Fusco, Alfredo; Grieco, M; Santoro, M.
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1.1 Articolo in rivista 1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, ROSA MARINA; Bucci, C; DE FRANCISCIS, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism 1.1 Articolo in rivista 1998 Cosma, Mp; Cardone, M; Carlomagno, Francesca; Colantuoni, V.
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer 1.1 Articolo in rivista 1999 Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) 1.1 Articolo in rivista 2003 Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
New therapeutic approaches to treat medullary thyroid carcinoma. 1.1 Articolo in rivista 2008 Schlumberger, M.; Carlomagno, Francesca; Baudin, E.; Bidart, J.; Santoro, Massimo
The Human Eps15 gene encoding a tyrosine kinase substrate is conserved in evolution and map to 1p31-1p32 1.1 Articolo in rivista 1994 Wong, Wt; Kraus, Mh; Carlomagno, Francesca; Zelano, A; Druck, T; Croce, Cm; Heubener, K; DI FIORE, Pp
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474 1.1 Articolo in rivista 2009 Carlomagno, Francesca; Guida, T.; Anaganti, S.; Provitera, L.; Kjaer, S.; Mcdonald, N. Q.; Ryan, A. J.; Santoro, Massimo
Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage 1.1 Articolo in rivista 2007 M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca
Activation of RET as a dominant transforming gene by germline mutatios of MEN2A and MEN2B 1.1 Articolo in rivista 1995 Santoro, Massimo; Carlomagno, Francesca; A., Romano; D. D., Bottaro; N. A., Dathan; M., Grieco; Fusco, Alfredo; Vecchio, Giancarlo; B., Matoskova; M. H., Kraus; P. P., Di Fiore
Molecular targeting of the RET kinase in thyroid cancer 8.02 Comunicazioni a Convegni o Seminari 2007 Santoro, Massimo; Carlomagno, F.
Pros and cons of cellular studies in developing new drugs for thyroid cancers 1.1 Articolo in rivista 2008 Salvatore, G.; Carlomagno, Francesca; Santoro, Massimo
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. 1.1 Articolo in rivista 2011 Vitagliano, Donata; De Falco, V.; Tamburrino, Anna; Coluzzi, S.; Troncone, Giancarlo; Chiappetta, G.; Ciardiello, F; Tortora, G.; Fagin, J.; Ryan, A. J.; Carlomagno, Francesca; Santoro, Massimo
Molecular Mechanism of RET in Human Cancer 2.1 Contributo in volume (Capitolo o Saggio) 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, F.; Fusco, Alfredo; Vecchio, Giancarlo
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 3.1 Monografia o trattato scientifico 2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. 1.1 Articolo in rivista 2009 Nappi, T.; Salerno, P.; Zitzelsberger, H.; Carlomagno, Francesca; Salvatore, G.; Santoro, Massimo
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 1.1 Articolo in rivista 1992 Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo